Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Daily News

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Shelley Wood

August 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Opinion Editor's Corner

Las Noticias y Blogs Más Populares de TCTMD en 2016

Shelley Wood

December 29, 2016

News Daily News

Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas

Todd Neale

July 14, 2016

News Daily News

Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says

Todd Neale

July 14, 2016

Advertisement

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

The Biggest News of 2019: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for March 2019

The Biggest News of 2018: TCTMD’s Top 10

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

TCTMD’s Top 10 Most Popular Stories for September 2017

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

TCTMD’s Top 10 Most Popular News and Features for 2016

Las Noticias y Blogs Más Populares de TCTMD en 2016

Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas

Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content